Doxorubicin-Induced Cardiomyopathy Latest Advances

Functional Evaluation of TRPC6 Missense Variants in Cancer Patients via Molecular Docking Analysis Compared with Patch Clamp Electrophysiology.

Journal: bioRxiv : the preprint server for biology

Published: January 09, 2026

Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies MMP16 and KCTD15 as risk loci.

Journal: medRxiv : the preprint server for health sciences

Published: December 25, 2025

In Vivo Immunomodulatory Programming of Circulating Myeloid Cells via Itaconic Acid Liposomes to Mitigate Myocarditis.

Journal: ACS nano

Published: December 17, 2025

Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications.

Journal: Cardiology in review

Published: November 06, 2025

Chemotherapy-Induced Cardiomyopathy in Pregnancy: A Multidisciplinary Approach.

Journal: JACC. Case reports

Published: October 30, 2025

Persistently increased CaMKIIδ autophosphorylation mediates pathologic SR Ca loss in a murine model of Doxorubicin-induced cardiomyopathy.

Journal: Journal of molecular and cellular cardiology plus

Published: October 30, 2025

Chemotherapy-Induced Cardiotoxicity in Breast Cancer: Mechanisms, Diagnostic Advances, and Emerging Protective Strategies.

Journal: American journal of physiology. Heart and circulatory physiology

Published: October 16, 2025

Reprogramming of the kynurenine pathway impairs NAD+ homeostasis and mediates doxorubicin-induced cardiotoxicity in mice.

Journal: Redox biology

Published: October 06, 2025

A Successful Spontaneous Delivery Case after Cardioprotective Drug Discontinuation for Severe Doxorubicin-Induced Cardiomyopathy.

Journal: International heart journal

Published: October 01, 2025

DHDK, a Plant-Derived Natural Small Molecule, Protects Against Doxorubicin-Induced Cardiotoxicity via the PPARG-CPT1B-FAO Axis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 29, 2025

Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.

Journal: HemaSphere

Published: September 25, 2025

Role of myocardium-derived exosomal miRNAs in doxorubicin-induced cardiomyopathy.

Journal: Gene

Published: September 15, 2025

Doxorubicin-Induced Cardiomyopathy Latest Advances

Find the Latest Research About Doxorubicin-Induced Cardiomyopathy

Functional Evaluation of TRPC6 Missense Variants in Cancer Patients via Molecular Docking Analysis Compared with Patch Clamp Electrophysiology.

Functional Evaluation of TRPC6 Missense Variants in Cancer Patients via Molecular Docking Analysis Compared with Patch Clamp Electrophysiology.

Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies MMP16 and KCTD15 as risk loci.

Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies MMP16 and KCTD15 as risk loci.

In Vivo Immunomodulatory Programming of Circulating Myeloid Cells via Itaconic Acid Liposomes to Mitigate Myocarditis.

In Vivo Immunomodulatory Programming of Circulating Myeloid Cells via Itaconic Acid Liposomes to Mitigate Myocarditis.

Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications.

Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications.

Chemotherapy-Induced Cardiomyopathy in Pregnancy: A Multidisciplinary Approach.

Chemotherapy-Induced Cardiomyopathy in Pregnancy: A Multidisciplinary Approach.

Persistently increased CaMKIIδ autophosphorylation mediates pathologic SR Ca loss in a murine model of Doxorubicin-induced cardiomyopathy.

Persistently increased CaMKIIδ autophosphorylation mediates pathologic SR Ca loss in a murine model of Doxorubicin-induced cardiomyopathy.

Chemotherapy-Induced Cardiotoxicity in Breast Cancer: Mechanisms, Diagnostic Advances, and Emerging Protective Strategies.

Chemotherapy-Induced Cardiotoxicity in Breast Cancer: Mechanisms, Diagnostic Advances, and Emerging Protective Strategies.

Reprogramming of the kynurenine pathway impairs NAD+ homeostasis and mediates doxorubicin-induced cardiotoxicity in mice.

Reprogramming of the kynurenine pathway impairs NAD+ homeostasis and mediates doxorubicin-induced cardiotoxicity in mice.

A Successful Spontaneous Delivery Case after Cardioprotective Drug Discontinuation for Severe Doxorubicin-Induced Cardiomyopathy.

A Successful Spontaneous Delivery Case after Cardioprotective Drug Discontinuation for Severe Doxorubicin-Induced Cardiomyopathy.

DHDK, a Plant-Derived Natural Small Molecule, Protects Against Doxorubicin-Induced Cardiotoxicity via the PPARG-CPT1B-FAO Axis.

DHDK, a Plant-Derived Natural Small Molecule, Protects Against Doxorubicin-Induced Cardiotoxicity via the PPARG-CPT1B-FAO Axis.

Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.

Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.

Role of myocardium-derived exosomal miRNAs in doxorubicin-induced cardiomyopathy.

Role of myocardium-derived exosomal miRNAs in doxorubicin-induced cardiomyopathy.